Literature DB >> 16824848

Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements.

Michael Lindstaedt1, Aydan Yazar, Alfried Germing, Markus K Fritz, Tim Holland-Letz, Andreas Mügge, Waldemar Bojara.   

Abstract

BACKGROUND: Correct assessment of the significance of left main stem lesions is of pivotal importance to the patient with coronary artery disease. On the basis of clinical and angiographic information alone, this evaluation often cannot be done reliably. Limited data suggest that coronary pressure-derived fractional flow reserve (FFR) supports decision making in equivocal left main disease.
METHODS: All patients presenting to our institution between June 1999 and June 2004 with intermediate left main coronary artery disease (40%-80% diameter stenosis by angiography), or in whom left main coronary disease was suspected but could not be quantified angiographically, were included in this prospective single-center follow-up study. If FFR was <0.75 along the left main stem, surgical revascularization was recommended; if FFR was >0.80, medical treatment or percutaneous coronary intervention elsewhere in the coronary tree was chosen. If FFR was in the "gray zone," between > or = 0.75 and < or = 0.80 treatment recommendation was dependent on additional individual criteria. Primary end points were freedom from death, myocardial infarction, any coronary revascularization procedure, and stroke.
RESULTS: Fifty-one patients (mean age 62.2 +/- 9.6 years, 41 male) were included. In 27 patients (53%), coronary artery bypass surgery was performed. The remaining 24 patients (47%) were treated nonsurgically. Mean follow-up was 29 +/- 16 months. Estimated survival after 4 years of follow-up was 81% among patients in the surgical group and 100% among patients in the nonsurgical group. Event-free survival was 66% in the surgical group and 69% in the nonsurgical group.
CONCLUSIONS: Fractional flow reserve is helpful to identify patients with intermediate left main disease in whom deferral of surgical revascularization is associated with excellent survival and low event rates.

Entities:  

Mesh:

Year:  2006        PMID: 16824848     DOI: 10.1016/j.ahj.2006.03.026

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

Review 1.  Myocardial fractional flow reserve. Its role in guiding PCI in stable coronary artery disease.

Authors:  M Lindstaedt; A Mügge
Journal:  Herz       Date:  2011-08       Impact factor: 1.443

2.  Quantification of I-123-meta-iodobenzylguanidine heart-to-mediastinum ratios: not so simple after all.

Authors:  Piotr J Slomka; Puja K Mehta; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2014-07-09       Impact factor: 5.952

3.  Use of coronary physiology in the catheterization laboratory to guide treatment in patients with coronary artery disease.

Authors:  Michael McDaniel; Habib Samady
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-02

4.  Fractional flow reserve application in everyday practice: adherence to clinical recommendations.

Authors:  Katia Orvin; Tamir Bental; Alon Eisen; Hana Vaknin-Assa; Abid Assali; Eli I Lev; David Brosh; Ran Kornowski
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

5.  Fractional flow reserve: the past, present and future.

Authors:  Jeong-Eun Kim; Bon-Kwon Koo
Journal:  Korean Circ J       Date:  2012-07-26       Impact factor: 3.243

Review 6.  Clinical Relevance of Coronary Fractional Flow Reserve: Art-of-state.

Authors:  Yohanes Adiputra; Shao-Liang Chen
Journal:  Chin Med J (Engl)       Date:  2015-05-20       Impact factor: 2.628

Review 7.  Unprotected left main percutaneous coronary intervention: integrated use of fractional flow reserve and intravascular ultrasound.

Authors:  Seung-Jung Park; Jung-Min Ahn; Soo-Jin Kang
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

8.  Evaluating the impact of fractional flow reserve-guided percutaneous coronary intervention in intermediate coronary artery lesions on the mode of treatment and their outcomes: An Iranian experience.

Authors:  Alireza Khosravi; Mohammad Reza Pourbehi; Masoud Pourmoghaddas; Afshin Ostovar; Mohammad Reza Akhbari; Fereshteh Ziaee-Bideh; Jafar Golshahi; Shahin Shirani
Journal:  ARYA Atheroscler       Date:  2015-03

9.  Invasive and non-invasive fractional flow reserve index in validation of hemodynamic severity of intracoronary lesions.

Authors:  Jarosław Wasilewski; Kryspin Mirota; Michał Hawranek; Lech Poloński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-06-17       Impact factor: 1.426

10.  The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study.

Authors:  Morteza Safi; Mohammad Ali Mehrabi; Saeed Alipour Parsa; Isa Khaheshi; Mohammadreza Naderian
Journal:  Acta Biomed       Date:  2018-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.